Skip to main content
. 2020 Aug 2;9(8):2481. doi: 10.3390/jcm9082481

Table 2.

Risk stratification of the patients with BRAFV600-positive papillary thyroid carcinomas.

Risk Stratification BRAFV600E in Plasma n = 24 Cases Wild-Type BRAF in Plasma n = 33 Cases p-Value
Low risk 4 (21%) 15 (79%) 0.02
Intermediate risk 8 (36%) 14 (64%) 0.48
High risk 12 (75%) 4 (25%) 0.002